Cytotoxic T Lymphocytes & the Clinical Course of Infection Vigorous HIV-1-specific cytotoxic T lymphocyte (CTL) activity in long-term nonprogressors (LTNPs) has suggested a causal relationship ...

Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...

Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...

Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...

Chugai introduces Lunsumio for intravenous infusion, a bispecific antibody to treat relapsed or refractory follicular lymphoma in Japan: Tokyo Thursday, March 20, 2025, 11:00 Hrs ...

The Trial in Progress poster includes an overview and study design of the TACTI-004 Phase III evaluating the Company’s MHC Class II agonist, eftilagimod alfa (efti) in combination with MSD’s (Merck & ...

Cellular damage occurs when sensitized T-lymphocytes and/or autoantibodies ... Some studies suggest that TPOAb may be cytotoxic to the thyroid. [249,250] The pathologic role of TgAb remains ...

Therapy-related B-cell acute lymphoblastic leukemia (B-ALL), a rare form of acute lymphoblastic leukemia (ALL), may develop in patients receiving cytotoxic treatments for a prior malignancy, according ...

Patients receiving ICIs were associated with a greater risk of developing RA, but lower risks for SLE and SSc.

Fate Therapeutics (NASDAQ:FATE – Get Free Report) and BioAtla (NASDAQ:BCAB – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two ...